NO20062870L - Anvendelse av katepsin K i alvorlige bentapsykdommer - Google Patents

Anvendelse av katepsin K i alvorlige bentapsykdommer

Info

Publication number
NO20062870L
NO20062870L NO20062870A NO20062870A NO20062870L NO 20062870 L NO20062870 L NO 20062870L NO 20062870 A NO20062870 A NO 20062870A NO 20062870 A NO20062870 A NO 20062870A NO 20062870 L NO20062870 L NO 20062870L
Authority
NO
Norway
Prior art keywords
cathepsin
bone loss
severe bone
loss disorders
inhibitors
Prior art date
Application number
NO20062870A
Other languages
English (en)
Inventor
Martin Missbach
Rainer Gamse
Ulrich Trechsel
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20062870L publication Critical patent/NO20062870L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Denne oppfinnelse vedrører generelt cathepsin K-hemmere og deres anvendelse i benvekst. Spesifikt vedrører oppfinnelsen anvendelsen av cathepsin K-hemmere for å stimulere ny bendannelse i pasienter som trenger det.
NO20062870A 2003-11-19 2006-06-19 Anvendelse av katepsin K i alvorlige bentapsykdommer NO20062870L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03026430 2003-11-19
PCT/EP2004/004155 WO2005049028A1 (en) 2003-11-19 2004-04-19 Use of cathepsin k inhibitors in severe bone loss diseases

Publications (1)

Publication Number Publication Date
NO20062870L true NO20062870L (no) 2006-08-18

Family

ID=34610055

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062870A NO20062870L (no) 2003-11-19 2006-06-19 Anvendelse av katepsin K i alvorlige bentapsykdommer

Country Status (16)

Country Link
US (1) US20070135448A1 (no)
EP (1) EP1686995A1 (no)
JP (1) JP2007511548A (no)
KR (1) KR20060107792A (no)
CN (1) CN1882343A (no)
AU (1) AU2004290874A1 (no)
BR (1) BRPI0416755A (no)
CA (1) CA2545723A1 (no)
IL (1) IL175436A0 (no)
IS (1) IS8498A (no)
MA (1) MA28174A1 (no)
MX (1) MXPA06005635A (no)
NO (1) NO20062870L (no)
TN (1) TNSN06147A1 (no)
TW (1) TW200526198A (no)
WO (1) WO2005049028A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0427380D0 (en) * 2004-12-14 2005-01-19 Novartis Ag Organic compounds
US20080076723A1 (en) * 2006-09-27 2008-03-27 Sylvan Pharmaceuticals Pty Ltd. Inhibition of cathepsin K activity and the treatment and prevention of disease
WO2008104271A2 (en) 2007-02-28 2008-09-04 Sanofi-Aventis Imaging probes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723407D0 (en) * 1997-11-05 1998-01-07 Ciba Geigy Ag Organic compounds
SK6572000A3 (en) * 1997-11-05 2000-10-09 Novartis Ag Dipeptide nitriles, process for the preparation thereof, their use as medicaments and pharmaceutical composition comprising them
JP3892187B2 (ja) * 1998-11-12 2007-03-14 生化学工業株式会社 環状アミド誘導体
GB0003111D0 (en) * 2000-02-10 2000-03-29 Novartis Ag Organic compounds
AR036375A1 (es) * 2001-08-30 2004-09-01 Novartis Ag Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
CA2532948A1 (en) * 2003-07-21 2005-02-17 Novartis Ag Combinations of a cathepsin k inhibitor and a bisphophonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss

Also Published As

Publication number Publication date
IS8498A (is) 2006-06-06
CA2545723A1 (en) 2005-06-02
TW200526198A (en) 2005-08-16
MA28174A1 (fr) 2006-09-01
KR20060107792A (ko) 2006-10-16
AU2004290874A1 (en) 2005-06-02
IL175436A0 (en) 2008-04-13
MXPA06005635A (es) 2006-08-17
JP2007511548A (ja) 2007-05-10
CN1882343A (zh) 2006-12-20
TNSN06147A1 (en) 2007-11-15
EP1686995A1 (en) 2006-08-09
BRPI0416755A (pt) 2007-02-27
WO2005049028A1 (en) 2005-06-02
US20070135448A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
NO20072558L (no) Mitotiske kineseinhibitorer og fremgangsmater for anvendelse derav
EP1485381B8 (en) Azolylaminoazine as inhibitors of protein kinases
AU2003220299A1 (en) Azinylaminoazoles as inhibitors of protein kinases
AU2003218215A1 (en) Azolylaminoazines as inhibitors of protein kinases
AU2003220300A1 (en) Compositions useful as inhibitors of protein kinases
NO20061092L (no) Heteroarvlaminosulfonvlfenvl-derivater for anvendelse som natrium- eller kalslumkanalblokkere i behandlingen av smerte
NO20052595L (no) Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser.
WO2005028475A3 (en) Compositions useful as inhibitors of protein kinases
TW200604168A (en) Azaindoles useful as inhibitors of rock and other protein kinases
ATE450530T1 (de) Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
ATE464303T1 (de) Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen
NO20082508L (no) Aminopyrimidiner anvendelige som kinaseinhibitorer
NO20074431L (no) Pyrrolopyrimidiner nyttige som proteinkinaseinhibitorer
MY151032A (en) Treatment of tnf? related disorders
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
NO20054371L (no) Somatostatin-dopamin kimaere analoger
NO20076186L (no) Mitotiske kinesininhibitorer og fremgangsmater for anvendelse derav
DK1485345T3 (da) Urokinaseinhibitorer, deres fremstilling og anvendelse
IL179206A0 (en) Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
NO20071466L (no) 3-substituerte-5- og 6-aminoalkyl indol-2-karboksylsyreamider og relaterte analoger som inhibitorer av kaseinkinase IE
WO2003072537A3 (en) Selective protein tyrosine phosphatatase inhibitors
NO20062870L (no) Anvendelse av katepsin K i alvorlige bentapsykdommer
NO20045343L (no) Ny kombinasjon for behandling av luftveisforstyrrelser
AU2002347984A1 (en) Use of norepinephrine reuptake inhibitors for the treatment of tic disorders

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application